位置:首页 > 蛋白库 > ABCD4_HUMAN
ABCD4_HUMAN
ID   ABCD4_HUMAN             Reviewed;         606 AA.
AC   O14678; A8K5L7; Q6IAQ0; Q96E75;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   03-AUG-2022, entry version 188.
DE   RecName: Full=Lysosomal cobalamin transporter ABCD4 {ECO:0000305|PubMed:27456980};
DE            EC=7.6.2.8 {ECO:0000269|PubMed:33845046, ECO:0000305|PubMed:28572511, ECO:0000305|PubMed:31467407};
DE   AltName: Full=ATP-binding cassette sub-family D member 4 {ECO:0000312|HGNC:HGNC:68};
DE   AltName: Full=PMP70-related protein;
DE            Short=P70R;
DE   AltName: Full=Peroxisomal membrane protein 1-like;
DE            Short=PXMP1-L;
DE   AltName: Full=Peroxisomal membrane protein 69;
DE            Short=PMP69;
GN   Name=ABCD4 {ECO:0000312|HGNC:HGNC:68}; Synonyms=PXMP1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9266848; DOI=10.1006/bbrc.1997.7102;
RA   Holzinger A., Kammerer S., Roscher A.A.;
RT   "Primary structure of human PMP69, a putative peroxisomal ABC-
RT   transporter.";
RL   Biochem. Biophys. Res. Commun. 237:152-157(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=9599016; DOI=10.1016/s0014-5793(98)00354-8;
RA   Holzinger A., Roscher A.A., Landgraf P., Lichtner P., Kammerer S.;
RT   "Genomic organization and chromosomal localization of the human peroxisomal
RT   membrane protein-1-like protein (PXMP1-L) gene encoding a peroxisomal ABC
RT   transporter.";
RL   FEBS Lett. 426:238-242(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9302272; DOI=10.1093/hmg/6.11.1925;
RA   Shani N., Jimenez-Sanchez G., Steel G., Dean M., Valle D.;
RT   "Identification of a fourth half ABC transporter in the human peroxisomal
RT   membrane.";
RL   Hum. Mol. Genet. 6:1925-1931(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-304 AND LYS-368.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH LMBRD1 AND MMACHC, AND SUBCELLULAR LOCATION.
RX   PubMed=25535791; DOI=10.3109/09687688.2014.990998;
RA   Deme J.C., Hancock M.A., Xia X., Shintre C.A., Plesa M., Kim J.C.,
RA   Carpenter E.P., Rosenblatt D.S., Coulton J.W.;
RT   "Purification and interaction analyses of two human lysosomal vitamin B12
RT   transporters: LMBD1 and ABCD4.";
RL   Mol. Membr. Biol. 31:250-261(2014).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH LMBRD1.
RX   PubMed=27456980; DOI=10.1038/srep30183;
RA   Kawaguchi K., Okamoto T., Morita M., Imanaka T.;
RT   "Translocation of the ABC transporter ABCD4 from the endoplasmic reticulum
RT   to lysosomes requires the escort protein LMBD1.";
RL   Sci. Rep. 6:30183-30183(2016).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-304 AND LYS-368.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-304 AND LYS-368.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, VARIANT MAHCJ CYS-319, INVOLVEMENT IN MAHCJ, MUTAGENESIS OF
RP   LYS-427; ASP-548 AND GLU-549, AND SUBCELLULAR LOCATION.
RX   PubMed=22922874; DOI=10.1038/ng.2386;
RA   Coelho D., Kim J.C., Miousse I.R., Fung S., du Moulin M., Buers I.,
RA   Suormala T., Burda P., Frapolli M., Stucki M., Nurnberg P., Thiele H.,
RA   Robenek H., Hohne W., Longo N., Pasquali M., Mengel E., Watkins D.,
RA   Shoubridge E.A., Majewski J., Rosenblatt D.S., Fowler B., Rutsch F.,
RA   Baumgartner M.R.;
RT   "Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism.";
RL   Nat. Genet. 44:1152-1155(2012).
RN   [11]
RP   INVOLVEMENT IN MAHCJ, VARIANT MAHCJ GLN-432, CHARACTERIZATION OF VARIANTS
RP   MAHCJ LYS-141 AND GLN-432, SUBCELLULAR LOCATION, INTERACTION WITH LMBRD1,
RP   MUTAGENESIS OF GLY-426; LYS-427 AND ASP-548, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=28572511; DOI=10.1074/jbc.m117.784819;
RA   Fettelschoss V., Burda P., Sagne C., Coelho D., De Laet C., Lutz S.,
RA   Suormala T., Fowler B., Pietrancosta N., Gasnier B., Bornhauser B.,
RA   Froese D.S., Baumgartner M.R.;
RT   "Clinical or ATPase domain mutations in ABCD4 disrupt the interaction
RT   between the vitamin B12-trafficking proteins ABCD4 and LMBD1.";
RL   J. Biol. Chem. 292:11980-11991(2017).
RN   [12]
RP   CATALYTIC ACTIVITY, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF
RP   ASN-141; TYR-319 AND LYS-427, SUBCELLULAR LOCATION, INTERACTION WITH
RP   LMBRD1, CHARACTERIZATION OF VARIANTS MAHCJ CYS-319 AND ASN-141, AND
RP   SUBUNIT.
RX   PubMed=33845046; DOI=10.1016/j.jbc.2021.100654;
RA   Kitai K., Kawaguchi K., Tomohiro T., Morita M., So T., Imanaka T.;
RT   "The lysosomal protein ABCD4 can transport vitamin B12 across liposomal
RT   membranes in vitro.";
RL   J. Biol. Chem. 296:100654-100654(2021).
RN   [13]
RP   VARIANTS THR-304 AND LYS-368.
RX   PubMed=12111378; DOI=10.1007/s100380200041;
RA   Iida A., Saito S., Sekine A., Mishima C., Kitamura Y., Kondo K.,
RA   Harigae S., Osawa S., Nakamura Y.;
RT   "Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes
RT   encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8,
RT   ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8.";
RL   J. Hum. Genet. 47:285-310(2002).
RN   [14]
RP   VARIANT MAHCJ LYS-141, AND INVOLVEMENT IN MAHCJ.
RX   PubMed=23141461; DOI=10.1016/j.ymgme.2012.10.005;
RA   Kim J.C., Lee N.C., Hwu P.W., Chien Y.H., Fahiminiya S., Majewski J.,
RA   Watkins D., Rosenblatt D.S.;
RT   "Late onset of symptoms in an atypical patient with the cblJ inborn error
RT   of vitamin B12 metabolism: diagnosis and novel mutation revealed by exome
RT   sequencing.";
RL   Mol. Genet. Metab. 107:664-668(2012).
RN   [15] {ECO:0007744|PDB:6JBJ}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) OF 2-606,
RP   CHARACTERIZATION OF VARIANTS MAHCJ CYS-319 AND GLN-432, MUTAGENESIS OF
RP   GLU-549, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=31467407; DOI=10.1038/s41422-019-0222-z;
RA   Xu D., Feng Z., Hou W.T., Jiang Y.L., Wang L., Sun L., Zhou C.Z., Chen Y.;
RT   "Cryo-EM structure of human lysosomal cobalamin exporter ABCD4.";
RL   Cell Res. 29:1039-1041(2019).
CC   -!- FUNCTION: Lysosomal membrane protein that transports cobalamin (Vitamin
CC       B12) from the lysosomal lumen to the cytosol in an ATP-dependent manner
CC       (PubMed:22922874,PubMed:33845046,PubMed:28572511,PubMed:31467407).
CC       Targeted by LMBRD1 lysosomal chaperone from the endoplasmic reticulum
CC       to the lysosomal membrane (PubMed:27456980). Then forms a complex with
CC       lysosomal chaperone LMBRD1 and cytosolic MMACHC to transport cobalamin
CC       across the lysosomal membrane (PubMed:25535791).
CC       {ECO:0000269|PubMed:22922874, ECO:0000269|PubMed:27456980,
CC       ECO:0000269|PubMed:28572511, ECO:0000269|PubMed:31467407,
CC       ECO:0000269|PubMed:33845046, ECO:0000303|PubMed:25535791}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an R-cob(III)alamin(out) + ATP + H2O = ADP + an R-
CC         cob(III)alamin(in) + H(+) + phosphate; Xref=Rhea:RHEA:17873,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:140785, ChEBI:CHEBI:456216;
CC         EC=7.6.2.8; Evidence={ECO:0000269|PubMed:33845046,
CC         ECO:0000305|PubMed:28572511, ECO:0000305|PubMed:31467407};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17874;
CC         Evidence={ECO:0000305|PubMed:33845046};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=426 uM for cobalamin {ECO:0000269|PubMed:33845046};
CC         Vmax=667 pmol/min/mg enzyme toward cobalamin
CC         {ECO:0000269|PubMed:33845046};
CC         Vmax=11.8 nmol/min/mg enzyme toward ATP
CC         {ECO:0000269|PubMed:31467407};
CC   -!- SUBUNIT: Homodimer or heterodimer (PubMed:27456980,PubMed:33845046).
CC       Interacts with LMBRD1; this interaction induces the translocation of
CC       ABCD4 from the ER to the lysosome membrane
CC       (PubMed:27456980,PubMed:28572511). Interacts with LMBRD1 and MMACHC;
CC       this interaction ensures the transport of cobalamin from the lysosome
CC       to the cytosol (PubMed:25535791). {ECO:0000269|PubMed:25535791,
CC       ECO:0000269|PubMed:27456980, ECO:0000269|PubMed:33845046}.
CC   -!- INTERACTION:
CC       O14678; O14678: ABCD4; NbExp=2; IntAct=EBI-714396, EBI-714396;
CC       O14678; Q9NUN5: LMBRD1; NbExp=7; IntAct=EBI-714396, EBI-2805231;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:27456980}; Multi-pass membrane protein
CC       {ECO:0000255}. Lysosome membrane {ECO:0000269|PubMed:22922874,
CC       ECO:0000269|PubMed:25535791, ECO:0000269|PubMed:27456980,
CC       ECO:0000269|PubMed:28572511, ECO:0000269|PubMed:33845046}; Multi-pass
CC       membrane protein {ECO:0000255}. Note=Targeted by LMBRD1 lysosomal
CC       chaperone to the lysosomal membrane. {ECO:0000269|PubMed:27456980,
CC       ECO:0000269|PubMed:28572511}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Methylmalonic aciduria and homocystinuria type cblJ (MAHCJ)
CC       [MIM:614857]: A disorder of cobalamin metabolism characterized by
CC       decreased levels of the coenzymes adenosylcobalamin (AdoCbl) and
CC       methylcobalamin (MeCbl). Clinical features include feeding
CC       difficulties, poor growth, hypotonia, lethargy, anemia, and
CC       developmental delay. {ECO:0000269|PubMed:22922874,
CC       ECO:0000269|PubMed:23141461, ECO:0000269|PubMed:28572511,
CC       ECO:0000269|PubMed:31467407, ECO:0000269|PubMed:33845046}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCD family.
CC       Peroxisomal fatty acyl CoA transporter (TC 3.A.1.203) subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Originally proposed to be a peroxisomal protein
CC       (PubMed:9266848). Recent studies have suggested its localization to the
CC       endoplasmic reticulum and within the lysosome (PubMed:27456980).
CC       {ECO:0000269|PubMed:27456980, ECO:0000269|PubMed:28572511,
CC       ECO:0000269|PubMed:33845046, ECO:0000269|PubMed:9266848}.
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC proteins;
CC       URL="http://abcm2.hegelab.org/search";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y14318; CAA74699.1; -; Genomic_DNA.
DR   EMBL; Y14319; CAA74699.1; JOINED; Genomic_DNA.
DR   EMBL; Y14320; CAA74699.1; JOINED; Genomic_DNA.
DR   EMBL; Y14321; CAA74699.1; JOINED; Genomic_DNA.
DR   EMBL; Y14322; CAA74699.1; JOINED; Genomic_DNA.
DR   EMBL; Y14323; CAA74699.1; JOINED; Genomic_DNA.
DR   EMBL; AF009746; AAB83967.1; -; mRNA.
DR   EMBL; BT007412; AAP36080.1; -; mRNA.
DR   EMBL; AK291332; BAF84021.1; -; mRNA.
DR   EMBL; CR457104; CAG33385.1; -; mRNA.
DR   EMBL; BC012815; AAH12815.1; -; mRNA.
DR   CCDS; CCDS9828.1; -.
DR   PIR; JC5604; JC5604.
DR   RefSeq; NP_005041.1; NM_005050.3.
DR   PDB; 6JBJ; EM; 3.60 A; A/B=2-606.
DR   PDBsum; 6JBJ; -.
DR   AlphaFoldDB; O14678; -.
DR   SMR; O14678; -.
DR   BioGRID; 111784; 39.
DR   IntAct; O14678; 17.
DR   STRING; 9606.ENSP00000349396; -.
DR   TCDB; 3.A.1.203.9; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; O14678; -.
DR   PhosphoSitePlus; O14678; -.
DR   BioMuta; ABCD4; -.
DR   EPD; O14678; -.
DR   jPOST; O14678; -.
DR   MassIVE; O14678; -.
DR   MaxQB; O14678; -.
DR   PaxDb; O14678; -.
DR   PeptideAtlas; O14678; -.
DR   PRIDE; O14678; -.
DR   ProteomicsDB; 48163; -.
DR   Antibodypedia; 184; 243 antibodies from 30 providers.
DR   DNASU; 5826; -.
DR   Ensembl; ENST00000356924.9; ENSP00000349396.4; ENSG00000119688.21.
DR   GeneID; 5826; -.
DR   KEGG; hsa:5826; -.
DR   MANE-Select; ENST00000356924.9; ENSP00000349396.4; NM_005050.4; NP_005041.1.
DR   UCSC; uc001xpr.3; human.
DR   CTD; 5826; -.
DR   DisGeNET; 5826; -.
DR   GeneCards; ABCD4; -.
DR   GeneReviews; ABCD4; -.
DR   HGNC; HGNC:68; ABCD4.
DR   HPA; ENSG00000119688; Low tissue specificity.
DR   MalaCards; ABCD4; -.
DR   MIM; 603214; gene.
DR   MIM; 614857; phenotype.
DR   neXtProt; NX_O14678; -.
DR   OpenTargets; ENSG00000119688; -.
DR   Orphanet; 369955; Methylmalonic acidemia with homocystinuria, type cblJ.
DR   PharmGKB; PA24403; -.
DR   VEuPathDB; HostDB:ENSG00000119688; -.
DR   eggNOG; KOG0060; Eukaryota.
DR   GeneTree; ENSGT00950000182955; -.
DR   HOGENOM; CLU_007587_7_0_1; -.
DR   InParanoid; O14678; -.
DR   OMA; RFWISAR; -.
DR   OrthoDB; 309052at2759; -.
DR   PhylomeDB; O14678; -.
DR   TreeFam; TF105205; -.
DR   BRENDA; 7.6.2.8; 2681.
DR   PathwayCommons; O14678; -.
DR   Reactome; R-HSA-5683329; Defective ABCD4 causes MAHCJ.
DR   Reactome; R-HSA-9758881; Uptake of dietary cobalamins into enterocytes.
DR   Reactome; R-HSA-9758890; Transport of RCbl within the body.
DR   SignaLink; O14678; -.
DR   BioGRID-ORCS; 5826; 27 hits in 1075 CRISPR screens.
DR   ChiTaRS; ABCD4; human.
DR   GeneWiki; ABCD4; -.
DR   GenomeRNAi; 5826; -.
DR   Pharos; O14678; Tbio.
DR   PRO; PR:O14678; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; O14678; protein.
DR   Bgee; ENSG00000119688; Expressed in right uterine tube and 176 other tissues.
DR   ExpressionAtlas; O14678; baseline and differential.
DR   Genevisible; O14678; HS.
DR   GO; GO:0043190; C:ATP-binding cassette (ABC) transporter complex; NAS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IBA:GO_Central.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0015420; F:ABC-type vitamin B12 transporter activity; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IBA:GO_Central.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005324; F:long-chain fatty acid transporter activity; IBA:GO_Central.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0009235; P:cobalamin metabolic process; IDA:MGI.
DR   GO; GO:0015889; P:cobalamin transport; IMP:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IBA:GO_Central.
DR   GO; GO:0015910; P:long-chain fatty acid import into peroxisome; IBA:GO_Central.
DR   GO; GO:0007031; P:peroxisome organization; IBA:GO_Central.
DR   GO; GO:0055085; P:transmembrane transport; NAS:UniProtKB.
DR   GO; GO:0042760; P:very long-chain fatty acid catabolic process; IBA:GO_Central.
DR   Gene3D; 1.20.1560.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF06472; ABC_membrane_2; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF90123; SSF90123; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Disease variant; Endoplasmic reticulum;
KW   Lysosome; Membrane; Nucleotide-binding; Reference proteome; Translocase;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..606
FT                   /note="Lysosomal cobalamin transporter ABCD4"
FT                   /id="PRO_0000093312"
FT   TRANSMEM        43..63
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        76..96
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        190..210
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        279..299
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TRANSMEM        314..334
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          39..332
FT                   /note="ABC transmembrane type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          389..603
FT                   /note="ABC transporter"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         421..428
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   VARIANT         141
FT                   /note="N -> K (in MAHCJ; does not affect ATPase activity.
FT                   Loss of cobalamin transport activity. Decreases interaction
FT                   with LMBD1. Does not affect lysosomal subcellular location;
FT                   dbSNP:rs776529140)"
FT                   /evidence="ECO:0000269|PubMed:23141461,
FT                   ECO:0000269|PubMed:28572511, ECO:0000269|PubMed:33845046"
FT                   /id="VAR_084972"
FT   VARIANT         172
FT                   /note="V -> I (in dbSNP:rs34992370)"
FT                   /id="VAR_048134"
FT   VARIANT         304
FT                   /note="A -> T (in dbSNP:rs4148077)"
FT                   /evidence="ECO:0000269|PubMed:12111378,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4,
FT                   ECO:0000269|Ref.8"
FT                   /id="VAR_020778"
FT   VARIANT         319
FT                   /note="Y -> C (in MAHCJ; strong decrease of ATPase
FT                   activity. Strong decrease of cobalamin transport activity;
FT                   dbSNP:rs201777056)"
FT                   /evidence="ECO:0000269|PubMed:22922874,
FT                   ECO:0000269|PubMed:31467407, ECO:0000269|PubMed:33845046"
FT                   /id="VAR_069097"
FT   VARIANT         350
FT                   /note="T -> R (in dbSNP:rs35073715)"
FT                   /id="VAR_048135"
FT   VARIANT         368
FT                   /note="E -> K (in dbSNP:rs3742801)"
FT                   /evidence="ECO:0000269|PubMed:12111378,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4,
FT                   ECO:0000269|Ref.8"
FT                   /id="VAR_020222"
FT   VARIANT         432
FT                   /note="R -> Q (in MAHCJ; decreases interaction with LMBD1.
FT                   Does not affect lysosomal subcellular location. Decreases
FT                   ATPase activity; dbSNP:rs745414252)"
FT                   /evidence="ECO:0000269|PubMed:28572511,
FT                   ECO:0000269|PubMed:31467407"
FT                   /id="VAR_084973"
FT   MUTAGEN         141
FT                   /note="N->A,D: Does not affect ATPase nor cobalamin
FT                   transport activities."
FT                   /evidence="ECO:0000269|PubMed:33845046"
FT   MUTAGEN         319
FT                   /note="Y->A: Decreases of ATPase activity. Decreases
FT                   cobalamin transport activity."
FT                   /evidence="ECO:0000269|PubMed:33845046"
FT   MUTAGEN         319
FT                   /note="Y->F: Does not affect ATPase activity. Does not
FT                   affect cobalamin transport activity."
FT                   /evidence="ECO:0000269|PubMed:33845046"
FT   MUTAGEN         426
FT                   /note="G->A: Decreases interaction with LMBD1. Decreases
FT                   colocalization with LMBD1. Decreases cobalamin transport
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:28572511"
FT   MUTAGEN         427
FT                   /note="K->A: Loss of ATPase activity. Loss of cobalamin
FT                   transport activity."
FT                   /evidence="ECO:0000269|PubMed:33845046"
FT   MUTAGEN         427
FT                   /note="K->L: Decreases interaction with LMBD1. Decreases
FT                   colocalization with LMBD1. Decreases cobalamin transport
FT                   activity. Reduces synthesis of adenosylcobalamin and
FT                   methylcobalamin."
FT                   /evidence="ECO:0000269|PubMed:22922874,
FT                   ECO:0000269|PubMed:28572511"
FT   MUTAGEN         548
FT                   /note="D->N: Decreases interaction with LMBD1. Reduces
FT                   synthesis of adenosylcobalamin and methylcobalamin."
FT                   /evidence="ECO:0000269|PubMed:22922874,
FT                   ECO:0000269|PubMed:28572511"
FT   MUTAGEN         549
FT                   /note="E->Q: Decreases ATPase activity. Reduces synthesis
FT                   of adenosylcobalamin and methylcobalamin."
FT                   /evidence="ECO:0000269|PubMed:22922874,
FT                   ECO:0000269|PubMed:31467407"
FT   CONFLICT        594
FT                   /note="G -> V (in Ref. 5; BAF84021)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        606
FT                   /note="E -> D (in Ref. 8; CAG33385)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   606 AA;  68597 MW;  2D88DEFED0EA0777 CRC64;
     MAVAGPAPGA GARPRLDLQF LQRFLQILKV LFPSWSSQNA LMFLTLLCLT LLEQFVIYQV
     GLIPSQYYGV LGNKDLEGFK TLTFLAVMLI VLNSTLKSFD QFTCNLLYVS WRKDLTEHLH
     RLYFRGRAYY TLNVLRDDID NPDQRISQDV ERFCRQLSSM ASKLIISPFT LVYYTYQCFQ
     STGWLGPVSI FGYFILGTVV NKTLMGPIVM KLVHQEKLEG DFRFKHMQIR VNAEPAAFYR
     AGHVEHMRTD RRLQRLLQTQ RELMSKELWL YIGINTFDYL GSILSYVVIA IPIFSGVYGD
     LSPAELSTLV SKNAFVCIYL ISCFTQLIDL STTLSDVAGY THRIGQLRET LLDMSLKSQD
     CEILGESEWG LDTPPGWPAA EPADTAFLLE RVSISAPSSD KPLIKDLSLK ISEGQSLLIT
     GNTGTGKTSL LRVLGGLWTS TRGSVQMLTD FGPHGVLFLP QKPFFTDGTL REQVIYPLKE
     VYPDSGSADD ERILRFLELA GLSNLVARTE GLDQQVDWNW YDVLSPGEMQ RLSFARLFYL
     QPKYAVLDEA TSALTEEVES ELYRIGQQLG MTFISVGHRQ SLEKFHSLVL KLCGGGRWEL
     MRIKVE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024